1
|
Domvri K, Zarogoulidis K, Zogas N, Zarogoulidis P, Petanidis S, Porpodis K, Kioseoglou E, Hohenforst-Schmidt W. Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer. J Cancer 2017; 8:3648-3656. [PMID: 29151951 PMCID: PMC5688917 DOI: 10.7150/jca.21783] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Accepted: 08/08/2017] [Indexed: 12/21/2022] Open
Abstract
Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been implicated in cancer treatment. Our objectives were to capture any potential anti-tumor effect of these drug combinations with chemotherapeutic agents in vitro. Methods: Theophylline as Methylxanthines, Roflumilast as phosphodiesterase type 4 (PDE4) inhibitor and Sildenafil as phosphodiesterase type 5 (PDE5) inhibitor are the drugs that we combined with the chemotherapeutic agents (Docetaxel, Cisplatin and Carboplatin) in vitro. Lung cancer cell lines (NCI-H1048-Small cell lung cancer-SCLC, A549- Non-small cell lung cancer-NSCLC) were purchased from ATCC LGC Standards. At indicated time-point, following 24h and 48h incubation, cell viability and apoptosis were measured with Annexin V staining by flow cytometry. Statistical analysis was performed by GraphPad Prism. Results: In SCLC, following 48h incubation, platinum combinations of carboplatin with roflumilast and sildenafil (p<0.001) and carboplatin with theophylline and sildenafil showed increased apoptosis when compared to carboplatin alone. Concerning the combinations of cisplatin, when combined with roflumilast, theophylline and sildenafil appeared with increased apoptosis of that alone (p<0.001, 24h and 48h incubation). In NSCLC, the 24h incubation was not enough to induce satisfactory apoptosis, except for the combination of cisplatin with roflumilast and theophylline (p<0.05) when compared to cisplatin alone. However, following 48h incubation, carboplatin plus sildenafil, carboplatin plus sildenafil, theophylline and roflumilast showed more cytotoxicity when compared to carboplatin alone (p<0.001). Docetaxel combinations showed no statistically significant results. Conclusion: The synergistic effect of PDE inhibitors with platinum-based agents has been demonstrated in lung cancer. Our suggestion is that these combinations could be used as additive and maintenance treatment in combination to antineoplastic agents in lung cancer patients.
Collapse
Affiliation(s)
- Kalliopi Domvri
- Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Konstantinos Zarogoulidis
- Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Nikolaos Zogas
- Gene and Cell Therapy Center, Hematology Department-Bone Marrow Transplantation Unit, “G. Papanikolaou” General Hospital, Thessaloniki, Greece
| | - Paul Zarogoulidis
- Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Savvas Petanidis
- Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Konstantinos Porpodis
- Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Efrosini Kioseoglou
- Gene and Cell Therapy Center, Hematology Department-Bone Marrow Transplantation Unit, “G. Papanikolaou” General Hospital, Thessaloniki, Greece
| | - Wolfgang Hohenforst-Schmidt
- Sana Clinic Group Franken, Department of Cardiology / Pulmonology / Intensive Care / Nephrology, ''Hof'' Clinics, University of Erlangen, Hof, Germany
| |
Collapse
|
2
|
Ruddarraju RR, Murugulla AC, Kotla R, Tirumalasetty MCB, Wudayagiri R, Donthabakthuni S, Maroju R. Design, synthesis, anticancer activity and docking studies of theophylline containing 1,2,3-triazoles with variant amide derivatives. MEDCHEMCOMM 2016; 8:176-183. [PMID: 30108703 DOI: 10.1039/c6md00479b] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/21/2016] [Accepted: 10/18/2016] [Indexed: 11/21/2022]
Abstract
A new series of theophylline analogues containing 1,2,3-triazoles with different amide groups (22-41) has been designed and synthesized, and their biological activities have been evaluated as potential anticancer agents. The anticancer activities of the synthesized compounds were studied in four cancer cell lines viz. lung (A549), colon (HT-29), breast (MCF-7) and melanoma (A375). Furthermore, these compounds were screened for computational ADME and Lipinski's analysis followed by molecular docking and binding energy calculations against the various therapeutic targets involved in cell proliferation. The in vitro results demonstrate that compounds 22, 27, 36 and 40 have pivotal anticancer activity. Among these, compounds 22 and 27 have significant cytotoxic activity in all three cell lines; the in silico docking studies also reveal that compounds 22, 27 and 36 have good dock scores, binding affinities and binding energies towards human epidermal growth factor receptor 2. This is the first report to demonstrate theophylline hybrids containing 1,2,3-triazoles as potential anticancer agents.
Collapse
Affiliation(s)
- Radhakrishnam Raju Ruddarraju
- Dr.MACS Bio-Pharma Pvt. Ltd , Factory: Plot-79/B&C , Pasamylaram , Medak (Dist)-502307 , Patancheru , Telangana , India .
| | - Adharvana Chari Murugulla
- Dr.MACS Bio-Pharma Pvt. Ltd , Factory: Plot-79/B&C , Pasamylaram , Medak (Dist)-502307 , Patancheru , Telangana , India .
| | - Ravindar Kotla
- Dr.MACS Bio-Pharma Pvt. Ltd , Factory: Plot-79/B&C , Pasamylaram , Medak (Dist)-502307 , Patancheru , Telangana , India .
| | - Muni Chandra Babu Tirumalasetty
- Bioinformatics Center , Division of Molecular Biology , Department of Zoology , Sri Venkateswara University , Tirupati-517 502 , Andhra Pradesh , India
| | - Rajendra Wudayagiri
- Bioinformatics Center , Division of Molecular Biology , Department of Zoology , Sri Venkateswara University , Tirupati-517 502 , Andhra Pradesh , India
| | - Shobha Donthabakthuni
- Dr.MACS Bio-Pharma Pvt. Ltd , Factory: Plot-79/B&C , Pasamylaram , Medak (Dist)-502307 , Patancheru , Telangana , India .
| | - Ravichandar Maroju
- Mahatma Gandhi Institute of Technology , Gandipet , Hyderabad-500 075 , Telangana , India
| |
Collapse
|
3
|
Ruddarraju RR, Murugulla AC, Kotla R, Chandra Babu Tirumalasetty M, Wudayagiri R, Donthabakthuni S, Maroju R, Baburao K, Parasa LS. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives. Eur J Med Chem 2016; 123:379-396. [PMID: 27487568 DOI: 10.1016/j.ejmech.2016.07.024] [Citation(s) in RCA: 77] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2016] [Revised: 07/10/2016] [Accepted: 07/12/2016] [Indexed: 10/21/2022]
Abstract
A new series of theophylline containing acetylene derivatives (6a-6b and 7-13) and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives (20-32) have been designed and synthesized. These compounds were screened for anticancer and antimicrobial activity. Further the computational docking and 2D QSAR were performed using MOE software to identify novel scaffolds. The results showed that compound 29 and 30 exhibit significant cytotoxic effect on all four cancer cells such as lung (A549), colon (HT-29), breast (MCF-7) and melanoma (A375) with IC50 values of 2.56, 2.19, 1.89, 4.89 μM and 3.57, 2.90, 2.10, 5.81 μM respectively. Whereas quite different results were observed for these compounds in antimicrobial studies. Compounds 11, 21 and 26 have exhibited significant minimum inhibitory concentrations (MIC) against Staphylococcus aureus, Bacillus cereus, Escherichia coli and Pseudomonas aeruginosa. The docking studies demonstrate that compound 27, 28, 29 and 30 have good dock score and binding affinities with various therapeutic targets in cancer cell proliferation. In addition these compounds have shown acceptable correlation with bioassay results in the regression plots generated in 2D QSAR models. This is the first report to demonstrate the theophylline containing acetylene derivatives and theophylline containing 1,2,3-triazole nucleoside hybrids as potential anticancer and antimicrobial agents with comprehensive in silico analysis.
Collapse
Affiliation(s)
| | - Adharvana Chari Murugulla
- Dr.MACS Bio-PharmaPvt.Ltd, Factory, Plot-79/B&C, Pasamylaram, Patancheru, Medak (Dist), 502307, Telangana, India.
| | - Ravindar Kotla
- Dr.MACS Bio-PharmaPvt.Ltd, Factory, Plot-79/B&C, Pasamylaram, Patancheru, Medak (Dist), 502307, Telangana, India
| | - Muni Chandra Babu Tirumalasetty
- Bioinformatics Center, Division of Molecular Biology, Department of Zoology, Sri Venkateswara University, Tirupati, 517 502, Andhra Pradesh, India
| | - Rajendra Wudayagiri
- Bioinformatics Center, Division of Molecular Biology, Department of Zoology, Sri Venkateswara University, Tirupati, 517 502, Andhra Pradesh, India
| | - Shobha Donthabakthuni
- Dr.MACS Bio-PharmaPvt.Ltd, Factory, Plot-79/B&C, Pasamylaram, Patancheru, Medak (Dist), 502307, Telangana, India
| | - Ravichandar Maroju
- Mahatma Gandhi Institute of Technology, Gandipet, Hyderabad, 500 075, Telangana, India
| | - K Baburao
- Department of Biotechnolgy, Bharathidasan University, Tiruchirappalli, India
| | | |
Collapse
|
4
|
CORSANO S, SCAPICCHI R, STRAPPAGHETTI G. ChemInform Abstract: Bronchodilator Activity of Theophylline Derivatives Substituted at the 7-Position. ACTA ACUST UNITED AC 2010. [DOI: 10.1002/chin.199513269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
5
|
Synthesis and antimicrobial activity of imidazo- and pyrimido[2,1-f]-theophyllines. MONATSHEFTE FUR CHEMIE 2008. [DOI: 10.1007/s00706-008-0854-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
6
|
Strappaghetti G, Corsano S, Barbaro R, Giannaccini G, Betti L. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists. Bioorg Med Chem 2001; 9:575-83. [PMID: 11310591 DOI: 10.1016/s0968-0896(00)00271-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A series of 8-substituted xanthines were synthesized and their affinity in vitro towards A1, A2A-adenosine receptors was evaluated by radioligand receptor binding assays. All compounds showed a greater affinity and selectivity towards the A1-adenosine receptor than theophylline. The compounds in which the n-proyl group is in 1-position of the xanthine nucleus and the pyridazinone system in 8-position is linked through a chain of two or four carbon atoms, showed the highest affinity and selectivity.
Collapse
Affiliation(s)
- G Strappaghetti
- Dipartimento di Chimica e Tecnologia del Farmaco, Università di Perugia, Italy.
| | | | | | | | | |
Collapse
|
7
|
Akgün H, Balkan A, Günay S, Erol K, Boydağ S. Some new 7-aryloxyalkyltheophyllines as bronchodilators. Eur J Med Chem 1997. [DOI: 10.1016/s0223-5234(97)87546-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
8
|
Corsano S, Strappaghetti G, Scapicchi R, Lucacchini A, Senatore G. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists. Arch Pharm (Weinheim) 1995; 328:654-8. [PMID: 7487422 DOI: 10.1002/ardp.19953280905] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Four new derivatives of 8-piperazine ethyl xanthine were synthesized and their bronchospasmolytic activity and A1-adenosine affinity were studied. Their relaxant action in the tracheal muscle was lower than that of theophylline and that of theophylline derivatives substituted at the 7-position. Only compound 9, where the methyl group in the 1-position of the theophylline was substituted by an isobutyl group, shows a good affinity towards the A1-adenosine receptor.
Collapse
Affiliation(s)
- S Corsano
- Istituto di Chimica Farmaceutica e Tecnica Farmaceutica, Università di Perugia, Italy
| | | | | | | | | |
Collapse
|